Modeling of a Bioengineered Immunomodulating Microenvironment for Cell Therapy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202304003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Simone Capuani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA. Hauptthemen laut MEDLINE: Cell- and Tissue-Based Therapy, Bioengineering, Models, Biological, Cellular Microenvironment. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Vivian L. Smith Foundation, Juvenile Diabetes Research Foundation International.
Abstract (Originalsprache)
Cell delivery and encapsulation platforms are under development for the treatment of Type 1 Diabetes among other diseases. For effective cell engraftment, these platforms require establishing an immune‐protected microenvironment as well as adequate vascularization and oxygen supply to meet the metabolic demands of the therapeutic cells. Current platforms rely on 1) immune isolating barriers and indirect vascularization or 2) direct vascularization with local or systemic delivery of immune modulatory molecules. Supported by experimental data, here a broadly applicable predictive computational model capable of recapitulating both encapsulation strategies is developed. The model is employed to comparatively study the oxygen concentration at different levels of vascularization, transplanted cell density, and spatial distribution, as well as with codelivered adjuvant cells. The model is then validated to be predictive of experimental results of oxygen pressure and local and systemic drug biodistribution in a direct vascularization device with local immunosuppressant delivery. The model highlights that dense vascularization can minimize cell hypoxia while allowing for high cell loading density. In contrast, lower levels of vascularization allow for better drug localization reducing systemic dissemination. Overall, it is shown that this model can serve as a valuable tool for the development and optimization of platform technologies for cell encapsulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
- College of Materials Science and Opto-Electronic Technology, University of Chinese Academy of Science (UCAS), Beijing, 100049, China.
- School of Medicine and Health Sciences, Tecnologico de Monterrey, Monterrey, NL, 64710, Mexico.
- Department of Surgery, Houston Methodist Hospital, Houston, TX, 77030, USA.
- Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, 77030, USA.
ORCID-Profile: Simone Capuani, Alessandro Grattoni
Förderung
- NIDDK NIH HHS
- Vivian L. Smith Foundation
- Juvenile Diabetes Research Foundation International
- Men of Distinction
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Capuani, S., Campa-Carranza, J. N., Hernandez, N., Chua, C. Y. X., & Grattoni, A. (2025). Modeling of a Bioengineered Immunomodulating Microenvironment for Cell Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202304003
Vancouver
Capuani S, Campa-Carranza JN, Hernandez N, Chua CYX, Grattoni A. Modeling of a Bioengineered Immunomodulating Microenvironment for Cell Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202304003
BibTeX
@article{Capuani2025,
author = {Capuani, Simone and Campa-Carranza, Jocelyn Nikita and Hernandez, Nathanael and Chua, Corrine Ying Xuan and Grattoni, Alessandro},
title = {Modeling of a Bioengineered Immunomodulating Microenvironment for Cell Therapy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202304003}
}
EUVIMED